Europe and the US collaborate on good clinical practice inspections
This article was originally published in Clinica
Executive Summary
With pressure mounting on regulators on both sides of the Atlantic as a result of the tendency for clinical trials to become increasingly globalised, the European Medicines Agency (EMEA) and the US FDA have decided to collaborate on international Good Clinical Practice (GCP) inspection activities.